Robert Half

RHI · NYSE

$33.85+$0.98 (+2.98%)TodayMarket closed · Oct 20, 6:34 PM ET

Prev close $32.87

RHI analyst rating

HoldConsensus of 7 analysts over the last 12 months. 29% rate it a buy.

Strong buy0
Buy2
Hold3
Underperform0
Sell2

12-month price target · 11 analysts

Average $35.34 (+4.4% upside)

Low: $20.20
Now: $33.85
High: $52.50

Upgrades and downgrades

The latest rating actions, newest first

RHI analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Goldman Sachs	Jul 24, 2026	Maintains	Sell	$26.00 → $29.00	43%
Truist Securities	Jul 22, 2026	Maintains	Buy	$40.00 → $50.00	61%
Goldman Sachs	Jul 14, 2026	Maintains	Sell	$23.00 → $26.00	43%
William Blair	Apr 21, 2026	Upgrade	Market Perform → Outperform	—	77%
Barclays	Mar 6, 2026	Maintains	Equal-Weight	$36.00 → $25.00	64%
BMO Capital	Feb 17, 2026	Maintains	Market Perform	$35.00 → $32.00	60%
Goldman Sachs	Feb 3, 2026	Maintains	Sell	$24.00 → $27.00	43%
Truist Securities	Feb 2, 2026	Maintains	Buy	$35.00 → $40.00	61%
JP Morgan	Jan 30, 2026	Maintains	Neutral	$29.00 → $31.00	64%
Barclays	Oct 23, 2025	Maintains	Equal-Weight	$45.00 → $36.00	64%

The case for and against

Updated Oct 14, 2025

Bull case

Robert Half Inc is projected to potentially return to annual revenues of approximately $7 billion, with an expected improvement in margins to around 13%, indicating an EBITDA exceeding $900 million. The company has adopted cost-cutting measures while still preserving key revenue-generating roles, suggesting management anticipates a 20%-30% upside based on historical productivity levels. Additionally, despite increased uncertainty affecting the conversion cycle at its subsidiary Protiviti, the weighted pipeline has shown year-over-year growth, highlighting a positive forward trajectory for the firm.

Bear case

Robert Half Inc. experienced a notable decline in revenues, reporting an 8% year-over-year decrease to $1.35 billion, falling short of consensus estimates of $1.41 billion. The staffing segments showed significant weakness, with Contract Talent Solutions and Permanent placement revenues declining by 14% and 10%, respectively, though Protiviti's revenue managed a modest 3% increase. Looking forward, revenue guidance indicates a continued downturn in Talent Solutions expected to decrease between 10% and 14%, suggesting ongoing challenges in the company's core staffing operations.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.